Cargando…

Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2

Several studies reported acute symptomatic seizures as a possible neurological complication of COVID-19 pneumonia. Apart from metabolic imbalances, hypoxia, and fever, other ictogenic mechanisms are likely related to an immune-mediated damage. The same mechanisms are shared by other respiratory viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Milano, Chiara, Turco, Francesco, Pizzanelli, Chiara, Pascazio, Alessia, Tagliaferri, Enrico, Nesti, Lorenzo, Pistello, Mauro, Capria, Anna Lisa, Menichetti, Francesco, Forfori, Francesco, Bonanni, Enrica, Siciliano, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661132/
https://www.ncbi.nlm.nih.gov/pubmed/34902662
http://dx.doi.org/10.1016/j.yebeh.2021.108470
_version_ 1784613325833764864
author Milano, Chiara
Turco, Francesco
Pizzanelli, Chiara
Pascazio, Alessia
Tagliaferri, Enrico
Nesti, Lorenzo
Pistello, Mauro
Capria, Anna Lisa
Menichetti, Francesco
Forfori, Francesco
Bonanni, Enrica
Siciliano, Gabriele
author_facet Milano, Chiara
Turco, Francesco
Pizzanelli, Chiara
Pascazio, Alessia
Tagliaferri, Enrico
Nesti, Lorenzo
Pistello, Mauro
Capria, Anna Lisa
Menichetti, Francesco
Forfori, Francesco
Bonanni, Enrica
Siciliano, Gabriele
author_sort Milano, Chiara
collection PubMed
description Several studies reported acute symptomatic seizures as a possible neurological complication of COVID-19 pneumonia. Apart from metabolic imbalances, hypoxia, and fever, other ictogenic mechanisms are likely related to an immune-mediated damage. The same mechanisms are shared by other respiratory viruses. Since neurotropic properties of SARS-CoV-2 have been questioned, we investigated whether SARS-CoV-2 has a similar ictogenic potential to other respiratory non-neurotropic viruses. We conducted a retrospective study identifying 1141 patients with SARS-CoV-2 pneumonia and 146 patients with H1N1/H3N2 pneumonia. We found a similar prevalence of seizures in the two viral pneumonia (1.05% with SARS-CoV-2 vs 2.05% with influenza; p = 0.26). We detailed clinical, electroencephalographic, and neuroradiological features of each patient, together with the hypothesized pathogenesis of seizures. Previous epilepsy or pre-existing predisposing conditions (i.e., Alzheimer’s disease, stroke, cerebral neoplasia) were found in one-third of patients that experienced seizures, while two-thirds of patients had seizures without known risk factors other than pneumonia in both groups. The prevalence of pre-existing predisposing conditions and disease severity indexes was similar in SARS-CoV-2 and H1N1/H3N2 pneumonia, thus excluding they could act as potential confounders. Considering all the patients with viral pneumonia together, previous epilepsy (p < 0.001) and the need for ventilatory support (p < 0.001), but not the presence of pre-existing predisposing conditions (p = 0.290), were associated with seizure risk. Our study showed that SARS-CoV-2 and influenza viruses share a similar ictogenic potential. In both these infections, seizures are rare but serious events, and can manifest without pre-existing predisposing conditions, in particular when pneumonia is severe, thus suggesting an interplay between disease severity and host response as a major mechanism of ictogenesis, rather than a virus-specific mechanism.
format Online
Article
Text
id pubmed-8661132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-86611322021-12-10 Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2 Milano, Chiara Turco, Francesco Pizzanelli, Chiara Pascazio, Alessia Tagliaferri, Enrico Nesti, Lorenzo Pistello, Mauro Capria, Anna Lisa Menichetti, Francesco Forfori, Francesco Bonanni, Enrica Siciliano, Gabriele Epilepsy Behav Brief Communication Several studies reported acute symptomatic seizures as a possible neurological complication of COVID-19 pneumonia. Apart from metabolic imbalances, hypoxia, and fever, other ictogenic mechanisms are likely related to an immune-mediated damage. The same mechanisms are shared by other respiratory viruses. Since neurotropic properties of SARS-CoV-2 have been questioned, we investigated whether SARS-CoV-2 has a similar ictogenic potential to other respiratory non-neurotropic viruses. We conducted a retrospective study identifying 1141 patients with SARS-CoV-2 pneumonia and 146 patients with H1N1/H3N2 pneumonia. We found a similar prevalence of seizures in the two viral pneumonia (1.05% with SARS-CoV-2 vs 2.05% with influenza; p = 0.26). We detailed clinical, electroencephalographic, and neuroradiological features of each patient, together with the hypothesized pathogenesis of seizures. Previous epilepsy or pre-existing predisposing conditions (i.e., Alzheimer’s disease, stroke, cerebral neoplasia) were found in one-third of patients that experienced seizures, while two-thirds of patients had seizures without known risk factors other than pneumonia in both groups. The prevalence of pre-existing predisposing conditions and disease severity indexes was similar in SARS-CoV-2 and H1N1/H3N2 pneumonia, thus excluding they could act as potential confounders. Considering all the patients with viral pneumonia together, previous epilepsy (p < 0.001) and the need for ventilatory support (p < 0.001), but not the presence of pre-existing predisposing conditions (p = 0.290), were associated with seizure risk. Our study showed that SARS-CoV-2 and influenza viruses share a similar ictogenic potential. In both these infections, seizures are rare but serious events, and can manifest without pre-existing predisposing conditions, in particular when pneumonia is severe, thus suggesting an interplay between disease severity and host response as a major mechanism of ictogenesis, rather than a virus-specific mechanism. Elsevier Inc. 2022-01 2021-12-10 /pmc/articles/PMC8661132/ /pubmed/34902662 http://dx.doi.org/10.1016/j.yebeh.2021.108470 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Communication
Milano, Chiara
Turco, Francesco
Pizzanelli, Chiara
Pascazio, Alessia
Tagliaferri, Enrico
Nesti, Lorenzo
Pistello, Mauro
Capria, Anna Lisa
Menichetti, Francesco
Forfori, Francesco
Bonanni, Enrica
Siciliano, Gabriele
Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2
title Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2
title_full Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2
title_fullStr Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2
title_full_unstemmed Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2
title_short Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2
title_sort ictogenesis of viral pneumonia: a comparison between sars-cov-2 and h1n1/h3n2
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661132/
https://www.ncbi.nlm.nih.gov/pubmed/34902662
http://dx.doi.org/10.1016/j.yebeh.2021.108470
work_keys_str_mv AT milanochiara ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT turcofrancesco ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT pizzanellichiara ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT pascazioalessia ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT tagliaferrienrico ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT nestilorenzo ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT pistellomauro ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT capriaannalisa ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT menichettifrancesco ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT forforifrancesco ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT bonannienrica ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2
AT sicilianogabriele ictogenesisofviralpneumoniaacomparisonbetweensarscov2andh1n1h3n2